¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"acute phase reaction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • swing phase
    Èçµê±â, À¯°¢±â
  • symbiotic phase
    °ø»ý±â
  • synaptic phase
    ½Ã³À½º±â, ¿¬Á¢±â
  • slow phase
    Àú¼Ó±â
  • vapor phase polymerization
    Áõ±â»óÁßÇÕ
  • washout phase
    ¾àÈ¿¼¼Ã´´Ü°è
  • yeast phase
    È¿¸ð±â
  • zygotene phase
    Á¢ÇÕ±â
  • anniversary reaction
    ÁÖ±â¹ÝÀÀ
  • anorectic reaction
    ½Ä¿å¾ïÁ¦¹ÝÀÀ
  • antigen-antibody reaction
    Ç׿øÇ×ü¹ÝÀÀ
  • antiglobulin reaction
    Çױ۷κҸ°¹ÝÀÀ
  • antitryptic reaction
    Çׯ®¸³½Å¹ÝÀÀ
  • anxiety reaction
    ºÒ¾È¹ÝÀÀ
  • arm tonus reaction
    À§ÆÈ±ÙÀ°±äÀå¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • adjustment reaction
    ÀûÀÀ¹ÝÀÀ
  • adverse reaction
    ºÎÀÛ¿ë
  • adverse drug reaction
    ¾à¹°ºÎÀÛ¿ë
  • aerobic reaction
    È£±â¼º¹ÝÀÀ
  • affective reaction
    Á¤µ¿¹ÝÀÀ
  • agglutination reaction
    ÀÀÁý¹ÝÀÀ
  • alarm reaction
    ¾Ë¸²¹ÝÀÀ
  • alcohol flush reaction
    ¾ËÄÚ¿ÃÈ«Á¶¹ÝÀÀ
  • alkaline reaction
    ¾ËÄ®¸®¹ÝÀÀ
  • allergic reaction
    ¾Ë·¹¸£±â¹ÝÀÀ, °ú¹Î¹ÝÀÀ
  • allograft reaction
    µ¿Á¾À̽ĹÝÀÀ
  • alternative reaction
    ±³´ë¹ÝÀÀ
  • anamnestic reaction
    ±â¿Õ¹ÝÀÀ
  • anaphylactic reaction
    ¾Æ³ªÇʶô½Ã½º¹ÝÀÀ, Ãʰú¹Î¹ÝÀÀ
  • anaphylactoid reaction
    À¯»ç¾Æ³ªÇʶô½Ã½º¹ÝÀÀ, À¯»çÃʰú¹Î¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • Wassermanns reaction
    ¹Ù¼¼¸£¸¸¹ÝÀÀ, ¸Åµ¶Ç÷û¹ÝÀÀ .
  • Weil Felix reaction
    ¿ÍÀÏ-Æç¸¯½º¹ÝÀÀ.
  • Weil Felix reaction
    ¹ÙÀÏ-Æç¸¯½º[¸®ÄÉÄ¡¾ÆÇ÷û]¹ÝÀÀ
  • Weil Felix reaction
    ¿ÍÀÏ-Æç¸¯½º¹ÝÀÀ.
  • Weil-Felix reaction
    ¿ÍÀÏ-Æç¸¯½º ¹ÝÀÀ
  • Widal reaction
    ºñ´Þ[ÀåÆ¼Çª½ºÇ÷û]¹ÝÀÀ
  • Zimmerman reaction
    Áü¸Þ¸£¸¸¹ÝÀÀ
  • acrosome reaction
    ֟ ¹ÝÀÀ
  • activator reaction
    Ȱ¼ºÈ­¹ÝÀÀ.
  • addition reaction
    ºÎ°¡¹ÝÀÀ.
  • adverse reaction
    À¯ÇØ(êóúª)¹ÝÀÀ, ¿ª(æ½)¹ÝÀÀ.
  • adverse reaction
    ºÎÀÛ¿ë
  • aerobic reaction
    È£±â¼º ¹ÝÀÀ
  • affective reaction
    Á¤µ¿¹ÝÀÀ, Á¤°¨¹ÝÀÀ
  • agglutination reaction
    ÀÀÁý¹ÝÀÀ(¡­Úãëë).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • phase evolution of fat suppression
    À§»ó ¼±È¸ Áö¹æ ¾ïÁ¦
  • phase frequency swap
    À§»ó Á֯ļö ±³È¯
  • phase image
    À§»ó ¿µ»ó
  • phase mismapping
    À§»ó ¿ÀÁöµµÀÛ¼º
  • phase of cornification
    °¢Áú±â
  • phase of decline
    °¨Åð±â, °¨¼Ò±â
  • phase of desquamation
    ¹Ú¸®±â
  • phase of incornification
    ºñ°¢Áú±â
  • phase of life problem
    ÀλýÁÖ±âÀÇ ¹®Á¦
  • phase of meditation
    Àẹ±â°£(íÖÜÑÑ¢Êà).
  • phase of rapid filling
    ±Þ¼ÓÃæ¸¸±â(ÐááÜ õöØ»Ðï).
  • phase of relaxation
    À̿ϱâ(ì¬èÐÐï).
  • phase of shortening
    ´ÜÃà±â(Ó­õêÑ¢).
  • phase offset multiplannar (POMP) imaging
    À§»ó ¿ÀÇÁ¼Â ´Ù¸é ¿µ»ó
  • phase plate
    À§»óÆÇ(êÈßÓ÷ù).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • reaction kinetics
    ¹ÝÀÀ ¼Óµµ·Ð(ÚãëëáÜÓøÖå)
  • reaction mixture
    ¹ÝÀÀ È¥ÇÕ¹°(ÚãëëûèùêÚª)
  • reaction of identity
    µ¿Áú¼º ¹ÝÀÀ(ÔÒòõàõÚãëë)
  • reaction of nonidentity
    ÀÌÁú¼º ¹ÝÀÀ(ì¶òõàõÚãëë)
  • reaction of partial identity
    ºÎºÐ µ¿Áú¼º(Ý»ÝÂÔÒòõàõ) ¹ÝÀÀ(Úãëë)
  • reaction order
    ¹ÝÀÀÂ÷¼ø(Úãëëó­â÷)
  • reaction paper cheomatography
    ¹ÝÀÀ ¿©Áö(Úãëëæ¤òµ) Å©·Î¸¶Åä±×·¡ÇÇ
  • reaction rate
    ¹ÝÀÀ ¼Óµµ·Ð(ÚãëëáÜÓøÖå)
  • rearrangement reaction
    Àç¹è¿­ ¹ÝÀÀ(î¢ÛÕÖªÚãëë)
  • reversible reaction
    °¡¿ª ¹ÝÀÀ(Úãëë)
  • Sakaguchi reaction
    »çÄ«±¸Âî ¹ÝÀÀ(Úãëë)
  • Salkowski reaction
    »ìÄÚÇÁ½ºÅ° ¹ÝÀÀ(Úãëë)
  • Sanger reaction
    »ý°Å ¹ÝÀÀ(Úãëë)
  • scalar reaction
    ½ºÄ®¶ó ¹ÝÀÀ(Úãëë)
  • Schardinger reaction
    »þ¸£µù°Å ¹ÝÀÀ(Úãëë)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
ASPS advanced sleep phase syndrome
CPIR cephalic-phase insulin release
CYCLOPS cyclically ordered phase sequence
DLP delipidized serum protein; direct linear plotting; dislocation of patella; distolinguopulpal; dyshar...
DSP decreased sensory perception; delayed sleep phase; desmoplakin; dibasic sodium phosphate; digital si...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
CP chronic phase
EFP early follicular phase
FP follicular phase
IPD interaural phase difference
LP luteal phase
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Napier's reaction
    ³ªÇÇ¾î ¹ÝÀÀ
    Ä®¶ó¾ÆÀÚ¸£¸¦ Áø´ÜÇÏ´Â µ¥ »ç¿ëµÇ´Â ¹ÝÀÀÀ¸·Î, Ç÷û 1 cc¿¡ Æ÷¸£¸»¸° ÇÑ ¹æ¿ïÀ» °¡ÇѸé, ±Û·ÎºÒ¸°ÀÇ Áõ°¡·Î ÀÎÇØ ¹éŹÀÌ ¹ß»ýÇÏ´Â Çö»óÀÌ´Ù.
  • Neill-Mooser reaction
    ´Ò-¹«Àú ¹ßÁø¿­ °Ë»ç
  • ninhydrin reaction
    ´ÑÈ÷µå¸° ¹ÝÀÀ
    µ¿ÀǾî=Abderhalden's reaction. ¸ðµç ´Ü¹éÁú ¹× ¾Æ¹Ì³ë»ê¿¡ ƯÀÌÇÑ ¹ÝÀÀÀ¸·Î, ²úÀ̸é û»öÀÌ µÇ°í, ÇǸ®µò¿¡ ÀÇÇØ ´õ¿í ÁøÇØÁö´Â ÀӽйÝÀÀ.
  • nitroso- ´ÏÆ®·Î¼Ò ¶Ç´Â ´ÏÆ®·Î½ÇÀ» ÇÔÀ¯Çϰí ÀÖÀ½À» ³ªÅ¸³»´Â Á¢µÎ¾î.

    nitrosoindol reaction

    ´ÏÆ®·Î Àε¹ ¹ÝÀÀ
  • nociceptive reaction
    Ä§ÇØ ¹ÝÀÀ
  • nonspecific reaction
    ºñƯÀÌ ¹ÝÀÀ
  • order of reaction
    ¹ÝÀÀ Â÷¼ö
  • overanxious reaction
    °úºÒ¾È ¹ÝÀÀ
  • oxidase reaction
    »êÈ­ È¿¼Ò ¹ÝÀÀ
  • pain reaction
    µ¿Åë ¹ÝÀÀ
  • panic reaction
    °øÈ² ¹ÝÀÀ
    ±ØµµÀÇ ¶Ç´Â ºÒÇÕ¸®ÇÑ °øÆ÷¿Í ºÒ¾È µîÀÇ ¹ÝÀÀÀ» º¸ÀÌ´Â °Í.
  • periosteal reaction
    °ñ¸· ¹ÝÀÀ
  • peritectic reaction
    Æ÷Á¤ ¹ÝÀÀ
    ÇÕ±ÝÀ» ¿ëÀ¶ »óÅ¿¡¼­ ³Ã°¢ÇÒ ¶§, ÃÊÁ¤°ú ³ª¸ÓÁö ¾×»óÀÌ ¹ÝÀÀÇÏ¿© »õ·Î¿î °í»óÀ» Çü¼ºÇÏ´Â ¹ÝÀÀ.
  • photoallergic reaction
    ±¤¾Ë·¹¸£±â ¹ÝÀÀ
  • photodynamic reaction
    ±¤¿ªÇÐ ¹ÝÀÀ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
acute contagious conjunctivitis An obsolete term for an acute conjunctivitis marked by intense hyperaemia and profuse mucopurulent discharge.
Synonym: acute epidemic conjunctivitis, pinkeye.
(05 Mar 2000)
acute crescentic glomerulonephritis <nephrology> A relatively uncommon (affecting 1 out of 10,000 people) form of acute glomerulonephritis that results in damage within the glomerulus of the kidney. There is rapid loss of kidney function with the formation of crescents on microscopic analysis (kidney biopsy). This disorder may result in acute glomerulonephritis or nephrotic syndrome, but ultimately results in renal failure and end-stage renal disease.
Symptoms include smoky coloured urine (pyuria), decreased urine output, swelling and hypertension. Any conditions which can cause a vasculitis increase the risk of this disorder. Some examples include lupus, Goodpasture's syndrome, Henoch-Schonlein purpura, IgA nephropathy, membranoproliferative glomerulonephritis, anti-glomerular basement membrane antibody disease, history for malignant tumours and exposure to hydrocarbon solvents.
(27 Sep 1997)
acute cutaneous leishmaniasis A form of cutaneous leishmaniasis characterised by rural distribution of human cases near infected rodents, particularly communal ground squirrels; characterised by acute rapidly developing dermal lesions that become severely inflamed, with moist necrotizing sores or ulcers that heal in two to eight months after a two to four month incubation period; among nonimmune immigrants, multiple lesions may develop, which heal more slowly and leave disabling or disfiguring scars. A strong delayed hypersensitivity and involvement of immune complexes play a role in necrosis, which is part of the healing process and of the strong specific immunity that follows.
Synonym: acute cutaneous leishmaniasis, rural cutaneous leishmaniasis, wet cutaneous leishmaniasis.
(05 Mar 2000)
acute decubitus ulcer A severe form of bedsore, of neutrophic origin, occurring in hemiplegia or paraplegia.
(05 Mar 2000)
acute delirium Delirium of recent, rapid onset.
(05 Mar 2000)
acute demyelinating polyneuropathy <neurology> A neurologic condition.
Synonym: Guillain-Barre syndrome.
Origin: Gr. Pathos = disease
(27 Sep 1997)
acute disease Disease having a short and relatively severe course.
(12 Dec 1998)
acute disseminated encephalomyelitis <radiology> Immune-mediated encephalitis (IME), ADE, allergic treatmentn to prior infection, begins 1-2 weeks after event, occus after viral infection or vaccination, affects corpus callosum and white matter (above and below tent), self-limited; steroids may help See also: white-matter disease, demyelinating disease
(12 Dec 1998)
acute disseminated myositis The occurrence of multiple foci of acute inflammation in the muscular tissue and overlying skin in various parts of the body, accompanied by fever and other signs of systemic infection.
See: dermatomyositis.
Synonym: acute disseminated myositis, pseudotrichinosis, pseudotrichiniasis.
(05 Mar 2000)
acute epidemic conjunctivitis An obsolete term for an acute conjunctivitis marked by intense hyperaemia and profuse mucopurulent discharge.
Synonym: acute epidemic conjunctivitis, pinkeye.
(05 Mar 2000)
acute epidemic leukoencephalitis A disease characterised by acute onset of fever, followed by convulsions, delirium, and coma, and associated with perivascular demyelination and haemorrhagic foci in the central nervous system.
Synonym: acute primary haemorrhagic meningoencephalitis, Strumpell's disease.
(05 Mar 2000)
acute extrinsic allergic alveolitis <radiology> No chest X-ray findings in 30-95%, diffuse acinar consolidative pattern (oedema and exudative filling of alveoli), basilar distribution, lymph node enlargement (unusual, more common with recurrence) see: extrinsic allergic alveolitis
(12 Dec 1998)
acute febrile illness An illness of sudden onset that manifests with fever.
(27 Sep 1997)
acute febrile neutrophilic dermatosis A rare dermatosis, predominant in women, of rapid onset and characterised by plaque-like lesions, usually multiple, on the face, neck, and upper extremities, accompanied by conjunctivitis, mucosal lesions, fever, malaise, arthralgia, and peripheral blood neutrophilia in many cases; biopsy reveals polymorphonuclear infiltrate of the dermis; rapid remission occurs with systemic steroid therapy.
Synonym: Sweet's disease.
(05 Mar 2000)
acute fibrinous pericarditis The usual lesion of acute pericarditis in which inflammation produces large quantities of fibrin.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 10
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 10
ÅëÇÕ°Ë»ö ¿Ï·á